Pictet Asset Management Holding SA »

Aeglea Biotherapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $24M 826k 29.41

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Aeglea Biotherapeutics

Fairmount Funds Management
Perceptive Advisors
VR Adviser
BlackRock
BlackRock
Braidwell
Commodore Capital
Vanguard Group
Deep Track Capital
State Street Corporation
Paradigm Biocapital Advisors
Assenagon Asset Management
Goldman Sachs Group
Geode Capital Management
Pictet Asset Management Holding SA

View all funds holding Aeglea Biotherapeutics